X-Message-Number: 1746 Date: Sun, 14 Feb 1993 23:56:34 +0100 From: (David Stodolsky RUC DK) Subject: CRYONICS: re MADison Avenue Meets Cryonics? In #1734 - MADison Avenue Meets Cryonics? [K.Q.Brown] writes: >If a *little* knowledge can be a dangerous thing, then I probably >am dangerous now. The book "Positioning: The Battle For Your Mind" Product design is a well explored scientific area with solid mathematical methods. It can be used to predict market impact of new products accurately. For example, your company wishes to launch a new coffee brand, but a market test in even a small city can cost millions of dollars. Your solution is to fund a survey that tries to predict the consumer response to a new coffee brand that is constructed to fit into a "hole" in the market, relative to products already positioned there. The researcher uses scaling methods to specify the taste, "image", etc, of the new brand, and predict the market share that can be captured by it. A study like this was actually performed by V. Stefflre in the '70s. The prediction was that there was room in the market for a new coffee. The following market test was a great success. The new coffee actually captured more of the market then expected. Unfortunately, the new coffee captured so much of the business of the sponsoring company's other coffee already established in the same market that launch of the new brand was dropped. Stefflre's "Possible future histories." _Futures_, June 1975, p. 230, might make interesting reading and gives a starting point for investigation of the literature in this area. However, I really wonder if sophisticated marketing approaches do not overlook the obvious. If someone knows that they are soon to be in a condition for which current medical technology has no answer, then they are more likely to try radical new methods. Cryonics, a possible method to get to the better equipped hospital of the future, is one of these. One population of persons who have this knowledge, and in most cases adequate time to make the preparations for suspension, are those with HIV infection. Given that ALCOR already has several patients from this group, this is hardly a novel observation. However, is this group being made aware of the cryonics option through a directed marketing plan? This group is very well organized in the USA and Europe and should be reachable via low cost and often free media, that are operated specifically for education of this group. David Stodolsky, c/o Jens Hoff, Political Science Dept., Copenhagen Univ., Rosenborggade 15, DK-1130 Copenhagen K, Denmark. Internet: Tel.: +45 31959282. Fax: + 45 33122613 Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=1746